23 results
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
18 Jun 24
Entry into a Material Definitive Agreement
8:36am
) Cerebral hemisphere 8% Race, n (%) Cerebellum Brain stem White 41 (53) 6% 8% Asian 5 (6) Black 2 (3) Multiple 3 (4) Other 6 (8) BRAF alteration (n=77
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
12 Jun 24
Regulation FD Disclosure
8:07am
% 8% Asian 5 (6) Black 2 (3) Multiple 3 (4) Other 6 (8) BRAF alteration (n=77) Not specified 20 (26) Number of lines of prior systemic therapy 17
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
30 May 24
Day One Announces Sale of Priority Review Voucher for $108 Million
8:35am
% Asian 5 (6) Black 2 (3) Multiple 3 (4) Other 6 (8) BRAF alteration (n=77) Not specified 20 (26) Number of lines of prior systemic therapy 17% Median
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
6 May 24
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
4:30pm
(%) White Asian Black Multiple Other Not specified 41 (53) 5 (6) 2 (3) 3 (4) 6 (8) 20 (26) Number of lines of prior systemic therapy Median (range) 1, n
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
24 Apr 24
Regulation FD Disclosure
8:01am
Male 40 (52) † 16% Female 37 (48) Cerebral hemisphere 8% Race, n (%) Cerebellum Brain stem White 41 (53) 6% 8% Asian 5 (6) Black 2 (3) Multiple 3 (4
8-K
EX-99.2
ei9e4y8
26 Feb 24
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.2
u0et3un aep
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
5zc3ky 3heq9idnufs
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.2
h8dy73cdp5rtmg
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.2
riu2duwk4ti4duca
30 Oct 23
Regulation FD Disclosure
8:12am
8-K
EX-99.2
aklsrzko
11 Sep 23
Regulation FD Disclosure
8:35am
8-K
EX-99.2
4s3koxf6j9
16 Aug 23
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
8:06am
8-K
EX-99.2
idqoui rtqro5x417ah
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.1
pjosw
12 Jun 23
Regulation FD Disclosure
8:07am
8-K
EX-99.1
ni0z ad8ehq1z5
5 Jun 23
Regulation FD Disclosure
6:08am
8-K
EX-99.2
4xqs84c
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
8-K
EX-99.2
fbhtqvr
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
2pc5s8f
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.2
amdhccx0n
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
lmes jtls
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm